Evogene Analyst Price Targets

Wall Street analyst price targets and consensus rating for Evogene (EVGN).

Price Target Range — 3 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$4Upside to Avg. PT+821.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 22, 2025	Lake Street	Ben Klieve	PT Cut	Buy	$5→$4
Nov 22, 2024	Lake Street	Ben Klieve	PT Cut	Buy	$12→$5
Aug 23, 2024	Lake Street	Ben Klieve	PT Cut	Buy	$30→$12

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Lake Street Maintains Buy on Evogene, Lowers Price Target to $3.5

Lake Street analyst Ben Klieve maintains Evogene (NASDAQ:EVGN) with a Buy and lowers the price target from $5 to $3.5.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Evogene, Lowers Price Target to $12

Lake Street analyst Ben Klieve maintains Evogene (NASDAQ:EVGN) with a Buy and lowers the price target from $30 to $12.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023

Benzinga Insights

PRO
Alliance Global Partners Initiates Coverage On Evogene with Buy Rating, Announces Price Target of $1.85

Alliance Global Partners analyst Ben Haynor initiates coverage on Evogene (NASDAQ:EVGN) with a Buy rating and announces Price Target of $1.85.

Benzinga Newsdesk

Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know

Benzinga Insights

PRO
Lake Street Maintains Buy on Evogene, Raises Price Target to $3

Lake Street analyst Ben Klieve maintains Evogene (NASDAQ:EVGN) with a Buy and raises the price target from $2 to $3.

Benzinga Newsdesk

Evogene Ltd

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Evogene Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Lake Street Maintains Buy on Evogene, Lowers Price Target to $3.5

PRO
Lake Street Maintains Buy on Evogene, Lowers Price Target to $12

Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023

PRO
Alliance Global Partners Initiates Coverage On Evogene with Buy Rating, Announces Price Target of $1.85

Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know

PRO
Lake Street Maintains Buy on Evogene, Raises Price Target to $3

People Also Watch

People Also Watch

Evogene Ltd

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Evogene Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLake Street Maintains Buy on Evogene, Lowers Price Target to $3.5

PROLake Street Maintains Buy on Evogene, Lowers Price Target to $12

Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023

PROAlliance Global Partners Initiates Coverage On Evogene with Buy Rating, Announces Price Target of $1.85

Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know

PROLake Street Maintains Buy on Evogene, Raises Price Target to $3

People Also Watch

People Also Watch

PRO
Lake Street Maintains Buy on Evogene, Lowers Price Target to $3.5

PRO
Lake Street Maintains Buy on Evogene, Lowers Price Target to $12

PRO
Alliance Global Partners Initiates Coverage On Evogene with Buy Rating, Announces Price Target of $1.85

PRO
Lake Street Maintains Buy on Evogene, Raises Price Target to $3